Searched for
GENERIC DRUGS US MARKET
Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...- Commerce ministry meeting industry, exporters on India-US trade on September 1India's Commerce Ministry will meet industry leaders on September 1 regarding trade performance. This meeting precedes Minister Piyush Goya...
- When volatility rises, will you panic or buy? Depends on the watchlist you build now: 5 large-cap stocks with upside potential of up to 32%Another worry has emerged for the markets, and it will drive the narrative in the short term. As usual, it comes from the US. The US Fed ha...
- Cipla Pharma license cancellation: FDA withdraws order after HC raps it for going 'overboard'Maharashtra FDA withdrew its order to cancel Cipla Pharma's drug sale license after court intervention. The Bombay High Court criticized th...
- Eli Lilly’s Mounjaro wins FDA approval for a major new cardiovascular benefitEli Lilly's Mounjaro received FDA approval for reducing heart attack and stroke risks. This new indication expands its use beyond diabetes ...
- Tukaram Mundhe cracks down: Maharashtra FDA cancels licence of Cipla's Pune unit over regulatory violations, Cipla contests actionMaharashtra FDA cancelled Cipla's Pune C&F unit drug sale licenses due to serious storage and recall issues. Inspectors found unauthorized ...
- Jubilant Generics receives show-cause notice demanding over Rs 105 crJubilant Generics received a Rs 105.5 crore GST show-cause notice from Uttarakhand authorities. The notice alleges improper availment of ta...
- Convening India's brightest minds: The Bharat Life Sciences Award’s Innovation Summit to spotlight life sciencesIndia sets its sights on becoming a frontrunner in innovation within the life sciences arena. The Bharat Life Sciences Award 2026 aims to h...
- Huawei plans for more AI pharma tie-ups, says healthcare presidentThe move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are ...
- A pill that doubles survival: Revolution's FDA-approved drug gives pancreatic cancer patients a fighting chanceThe US FDA has approved Revolution Medicines' pancreatic cancer drug Rasonque. This once-daily pill doubles survival for patients with adva...
- DRL, Emcure get approval to make breakthrough HIV drugIndia's drug regulator has cleared the path for local lenacapavir manufacturing. Two Indian pharmaceutical companies received waivers for l...
- Kroger savings club settlement: You may be eligible for payment in $17 million class-action settlement over pricing claims; check eligibility, deadline, payout and moreKroger customers may receive a share of a proposed $17 million class-action settlement. This settlement addresses allegations of overchargi...
- NFO Insight: Invesco India Pharma and Healthcare Fund opens for subscription. Right time to invest in pharma funds?Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...
- Indian pharma has little reason to fear TrumpUS tariff threats on Indian generic drugs face significant obstacles. These duties could increase American healthcare costs and potentially...
- Zydus Lifesciences gets USFDA nod for generic ascorbic acid injectionZydus Lifesciences secured final USFDA approval for its generic ascorbic acid injection. This approval is for the treatment of scurvy in sp...
- India's pharma sector must shift from cost competitiveness to innovation, global quality: ExpertsFor the growth of India's pharmaceutical sector, prioritizing innovation and advanced manufacturing is essential. Experts indicate that inc...
- Lupin shares in focus after USFDA nod for drug to treat excessive daytime sleepinessLupin received USFDA approval for generic Pitolisant Tablets, strengthening its US portfolio and specialty generics presence. Shares remain...
- Stocks in news: Airtel, Paytm, SpiceJet, ONGC and ZEEMarkets extended their losing streak for a fifth consecutive session on Monday. Airtel Payments Bank appointed Shabnam Sinha as its new cha...
- Lupin gets USFDA nod for generic tablets to treat excessive daytime sleepinessPharma major Lupin Ltd announced receiving final USFDA approval for its generic Pitolisant tablets. These tablets are indicated for treatin...
- Need one or two Indian pharma firms to be among global top 5: PM ModiPrime Minister Modi urged Indian pharmaceutical companies to reach global top five. The Indian pharma industry ranks third globally by volu...
Load More
